Abstract
The clinical presentation of heart disease is different between men and women and this distinction is pivotal for a correct diagnosis and an adequate treatment. However, the definition of symptoms classically associated with heart disease is mainly based on the characteristics of those reported in men. Chest pain or chest discomfort in women are therefore often regarded as “atypical” and these symptoms tend to be misdiagnosed and under- treated. Further, women are less likely to receive appropriate invasive and non invasive investigations. They are less likely to refer for medical help and tend to present late in the process of the cardiovascular disease, with delays in the start of effective treatment. Therefore, a gender-specific assessment of cardiovascular risk is strongly advised for patients presenting with symptoms suggestive of heart disease.
Keywords: Coronary disease, angina, heart disease, women, misdiagnosed, symptomatology, atypical, palpitations, dyspnea, scapula, angiograms, prognosis, dyslipidemia, atherogenic, stratification, diastolic, systolic, intramural
Current Pharmaceutical Design
Title: Gender Differences in the Clinical Presentation of Heart Disease
Volume: 17 Issue: 11
Author(s): Peter Collins, Cristiana Vitale, Ilaria Spoletini and Giuseppe Barbaro
Affiliation:
Keywords: Coronary disease, angina, heart disease, women, misdiagnosed, symptomatology, atypical, palpitations, dyspnea, scapula, angiograms, prognosis, dyslipidemia, atherogenic, stratification, diastolic, systolic, intramural
Abstract: The clinical presentation of heart disease is different between men and women and this distinction is pivotal for a correct diagnosis and an adequate treatment. However, the definition of symptoms classically associated with heart disease is mainly based on the characteristics of those reported in men. Chest pain or chest discomfort in women are therefore often regarded as “atypical” and these symptoms tend to be misdiagnosed and under- treated. Further, women are less likely to receive appropriate invasive and non invasive investigations. They are less likely to refer for medical help and tend to present late in the process of the cardiovascular disease, with delays in the start of effective treatment. Therefore, a gender-specific assessment of cardiovascular risk is strongly advised for patients presenting with symptoms suggestive of heart disease.
Export Options
About this article
Cite this article as:
Collins Peter, Vitale Cristiana, Spoletini Ilaria and Barbaro Giuseppe, Gender Differences in the Clinical Presentation of Heart Disease, Current Pharmaceutical Design 2011; 17 (11) . https://dx.doi.org/10.2174/138161211795656927
DOI https://dx.doi.org/10.2174/138161211795656927 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Genetics of Small-Vessel Disease
Current Medicinal Chemistry Clinical Evaluation of Natural History of Peyronie’s Disease: Our Experience, Old Myths and New Certainties
Inflammation & Allergy - Drug Targets (Discontinued) Dyslipidemia, Vascular Atheroma and Statins
Current Vascular Pharmacology Utility of Anti-Arrhythmic Medications in ‘Lone Atrial Fibrillation’
Current Pharmaceutical Design Anti Inflammatory and Anti Arthritic Activity of Different Milk Based Formulation of Curcumin in Rat Model
Current Drug Delivery Aptamers in Drug Design: An Emerging Weapon to Fight a Losing Battle
Current Drug Targets The Emerging Role of microRNA in Stroke
Current Topics in Medicinal Chemistry Fatty Acid Intakes and Coronary Heart Disease Mortality in Japan: NIPPON DATA90, 1990-2005
Current Nutrition & Food Science Modulation of MMP-9 Pathway by Lycopene in Macrophages and Fibroblasts Exposed to Cigarette Smoke
Inflammation & Allergy - Drug Targets (Discontinued) Recent Developments in Patents Targeting Toll-Like Receptor Genes
Recent Patents on DNA & Gene Sequences Neuroprotective Therapies for Alzheimers Disease
Current Pharmaceutical Design Environmental Factors and Hypertension
Current Pharmaceutical Design Novel Inflammatory Biomarkers in Coronary Artery Disease: Potential Therapeutic Approaches
Current Medicinal Chemistry Multimodality Imaging of RNA Interference
Current Medicinal Chemistry Total Polyphenols and Bioactivity of Seeds and Sprouts in Several Legumes
Current Pharmaceutical Design Apolipoprotein(a) in the Carotid Artery Plaque: Evidence for Proteolytic and Pro-Inflammatory Modifications
Vascular Disease Prevention (Discontinued) The Nutrigenetics and Pharmacogenetics of Vitamin D Pathways
Current Pharmacogenomics and Personalized Medicine Nanotechnology and Alzheimer's Disease: What has been Done and What to Do'
Current Medicinal Chemistry Insights into the Pathogenesis and Intervention of Atherosclerosis
Vascular Disease Prevention (Discontinued) The Impact of Type 2 Diabetes on Women’s Health and Well-being During Their Reproductive Years: A Mixed-methods Systematic Review
Current Diabetes Reviews